Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease

Belgique Nouvelles Nouvelles

Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 71%

The efficacy, tolerability, and safety of various anti-Parkinson's drugs.

By Vijay Kumar MalesuOct 23 2023Reviewed by Lily Ramsey, LLM In a recent study published in npj Parkinson's Disease, a group of researchers concisely compared the efficacy, tolerability, and safety of various anti-Parkinson's drugs used with levodopa, utilizing a network meta-analysis approach.

Existing NMAs often exclude newly available drugs or certain drug forms and stages of PD, and they typically use Unified Parkinson's Disease Rating Scale scores rather than off-time reduction, which is more relevant for patients with advanced PD experiencing motor fluctuations. The scope was narrowed to randomized controlled trials published in English, involving Parkinson's patients experiencing motor fluctuations and comparing placebo with selected Parkinson's drugs or among the drugs themselves.

The research also thoroughly examined any inconsistencies or heterogeneities within the collected data, underpinning the study's thoroughness and credibility. Regarding discontinuation due to all causes, pramipexole, and ropinirole showed a significantly lower risk than placebo, with ropinirole ranking the highest in this outcome, followed by pramipexole, safinamide, and ropinirole ER.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Ben Fogle wants to bring back Castaway 25 years after groundbreaking show endedBen Fogle wants to bring back Castaway 25 years after groundbreaking show endedThe 49-year-old presented the show in 2000.
Lire la suite »

King’s Cross was more dangerous than Jordan, says passenger with Parkinson’sKing’s Cross was more dangerous than Jordan, says passenger with Parkinson’sJohn Hinson said he felt safer while on holiday in the Middle East than waiting for a train at King’s Cross station.
Lire la suite »

King’s Cross was more dangerous than Jordan, says passenger with Parkinson’sKing’s Cross was more dangerous than Jordan, says passenger with Parkinson’sJohn Hinson said he felt safer while on holiday in the Middle East than waiting for a train at King’s Cross station.
Lire la suite »

Glasgow's Golf It on mission to help chronic illness sufferers get into the gameGlasgow's Golf It on mission to help chronic illness sufferers get into the gameGolf It! at Hogganfield Park have launched weekly sessions for Glaswegians battling dementia, Parkinson's, depression and loneliness - the sessions take place every Monday.
Lire la suite »

Study finds ice cream, potato chips may be as addictive as drugsStudy finds ice cream, potato chips may be as addictive as drugsThere might be some truth to the potato chip ad that boasts, 'You can't eat just one.'
Lire la suite »



Render Time: 2025-03-09 16:39:35